<p>根據 Citizens Financial Group Inc. RI 最近向證券交易委員會提交的 13F 文件，該公司在第二季度收購了 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免費報告）的新股份。該基金收購了 3,729 股公司股票，價值約為 276,000 美元。</p>
<ul>
<li>GE 航空航天：卡塔爾交易推動數十億美元增長引擎</li>
</ul>
<p>其他大型投資者最近也買賣了該公司的股票。摩根大通在第一季度將其在 GE HealthCare Technologies 的股份增加了 49.9%。摩根大通目前擁有 5,140,549 股公司股票，價值 414,894,000 美元，在此期間又購買了 1,711,963 股。Nuveen LLC 在第一季度收購了價值 77,058,000 美元的 GE HealthCare Technologies 新股份。Eminence Capital LP 在第一季度將其在 GE HealthCare Technologies 的持股增加了 38.7%。Eminence Capital LP 目前擁有 1,819,129 股公司股票，價值 146,822,000 美元，在此期間又購買了 507,101 股。加拿大養老金計劃投資委員會在第一季度將其在 GE HealthCare Technologies 的股份增加了 15.2%。加拿大養老金計劃投資委員會目前擁有 3,111,398 股公司股票，價值 251,121,000 美元，在上個季度又購買了 409,636 股。最後，瑞穗市場開曼有限公司在第二季度收購了價值約 29,628,000 美元的 GE HealthCare Technologies 新股份。目前 82.06% 的股票由機構投資者持有。</p>
<h2>GE HealthCare Technologies 股票上漲 1.8%</h2>
<p>GEHC 股票週四開盤價為 72.31 美元。該股票的 50 日簡單移動平均線為 74.77 美元，200 日簡單移動平均線為 73.76 美元。GE HealthCare Technologies Inc.的 12 個月低點為 57.65 美元，12 個月高點為 94.80 美元。該公司的市值為 329.4 億美元，市盈率為 14.94，市盈增長比率為 2.97，貝塔值為 1.13。該公司的速動比率為 0.95，流動比率為 1.18，債務與股本比率為 0.83。</p>
<ul>
<li>霍尼韋爾的拆分：HON 股票對投資者來説是個好交易嗎？</li>
</ul>
<p>GE HealthCare Technologies（NASDAQ:GEHC - 獲取免費報告）最近於 10 月 29 日（星期三）發佈了季度財報。該公司報告季度每股收益為 1.07 美元，超出市場共識預期的 1.05 美元 0.02 美元。該公司季度收入為 51.4 億美元，而分析師預期為 50.7 億美元。GE HealthCare Technologies 的股本回報率為 22.52%，淨利潤率為 10.94%。與去年同期相比，該公司的收入增長了 5.8%。去年同期，該公司每股收益為 1.14 美元。GE HealthCare Technologies 已將其 2025 財年的指導目標設定為每股收益 4.510-4.630 美元。平均而言，股票分析師預測 GE HealthCare Technologies Inc.在當前財年將發佈每股收益 4.68 美元。</p>
<h2>GE HealthCare Technologies 宣佈分紅</h2>
<p>該公司最近還宣佈了一項季度分紅，已於 11 月 14 日（星期五）支付。10 月 24 日（星期五）登記的投資者獲得了 0.035 美元的分紅。除息日為 10 月 24 日（星期五）。這代表着年化分紅為 0.14 美元，收益率為 0.2%。GE HealthCare Technologies 的派息比率目前為 2.89%。</p>
<h2>分析師設定新目標價</h2>
<ul>
<li>超聲波減肥：GE HealthCare 與諾和諾德的合作</li>
</ul>
<p>一些股票研究分析師對該公司進行了評論。花旗集團在 10 月 7 日（星期二）的研究報告中將 GE HealthCare Technologies 的評級從 “買入” 下調至 “中性”，並將其目標價從 93.00 美元下調至 83.00 美元。巴克萊在 10 月 13 日（星期一）的研究報告中對 GE HealthCare Technologies 的股票進行了覆蓋，給予 “持平” 評級和 86.00 美元的目標價。BTIG 研究在 10 月 29 日（星期三）的研究報告中設定了 GE HealthCare Technologies 的目標價為 87.00 美元。摩根士丹利在 10 月 30 日（星期四）將 GE HealthCare Technologies 的目標價從 74.00 美元上調至 80.00 美元，並給予該公司 “持平” 評級。最後，Evercore ISI 在 10 月 30 日（星期四）將 GE HealthCare Technologies 的目標價從 88.00 美元上調至 92.00 美元，並給予該股票 “跑贏大盤” 評級。六位投資分析師對該股票給予 “買入” 評級，六位分析師對該公司的股票給予 “持有” 評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “適度買入”，共識目標價為 86.10 美元。</p>
<p><strong>獲取我們對 GE HealthCare Technologies 的最新股票分析</strong></p>
<h2>GE HealthCare Technologies 簡介</h2>
<p>（免費報告）</p>
<p>GE HealthCare Technologies Inc.從事產品、服務和補充數字解決方案的開發、製造和營銷，這些產品、服務和解決方案用於美國、加拿大及國際上患者的診斷、治療和監測。該公司通過四個部門運營：成像、超聲、患者護理解決方案和藥物診斷。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票比 GE HealthCare Technologies 更好</li>
<li>八月值得關注的三隻最佳零售股票</li>
<li>onsemi 對其自身股票下注 60 億美元</li>
<li>大盤股的定義及如何投資</li>
<li>HIMS 經歷了過山車，投資者應該上車嗎？</li>
<li>什麼是二次公開募股？投資者需要知道什麼</li>
<li>以這三隻反彈冠軍強勢結束年末</li>
</ul>
<p><strong>想看看其他對 GEHC 持有股份的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 GE HealthCare Technologies 嗎？</h2>
<p>在考慮 GE HealthCare Technologies 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 GE HealthCare Technologies 並不在名單上。</p>
<p>雖然 GE HealthCare Technologies 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

GEHC

<p>公民金融集團（Citizens Financial Group Inc.）在第二季度收購了 3,729 股 GE 醫療科技公司（GE HealthCare Technologies Inc.），價值 27.6 萬美元。這項投資是機構投資於 GE 醫療的更廣泛趨勢的一部分。分析師對該股票的評級褒貶不一，有些分析師下調了評級，而另一些則提高了目標價。GE 醫療最近公佈的季度收益超出預期，並宣佈了分紅。該股票的市值為 329.4 億美元，82.06% 的股份由機構投資者持有</p>

<p>Citizens Financial Group Inc. RI acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,729 shares of the company's stock, valued at approximately $276,000.</p>
<div class="lb-trans"><p>根據 Citizens Financial Group Inc. RI 最近向證券交易委員會提交的 13F 文件，該公司在第二季度收購了 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免費報告）的新股份。該基金收購了 3,729 股公司股票，價值約為 276,000 美元。</p>
</div><ul>
<li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li>
</ul>
<div class="lb-trans"><ul>
<li>GE 航空航天：卡塔爾交易推動數十億美元增長引擎</li>
</ul>
</div><p>Other large investors have also recently bought and sold shares of the company. JPMorgan Chase &amp; Co. lifted its stake in shares of GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase &amp; Co. now owns 5,140,549 shares of the company's stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the period. Nuveen LLC acquired a new stake in GE HealthCare Technologies in the first quarter worth $77,058,000. Eminence Capital LP grew its holdings in GE HealthCare Technologies by 38.7% in the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company's stock worth $146,822,000 after purchasing an additional 507,101 shares during the period. Canada Pension Plan Investment Board increased its stake in GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company's stock valued at $251,121,000 after purchasing an additional 409,636 shares in the last quarter. Finally, Mizuho Markets Cayman LP acquired a new position in shares of GE HealthCare Technologies during the second quarter valued at about $29,628,000. 82.06% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他大型投資者最近也買賣了該公司的股票。摩根大通在第一季度將其在 GE HealthCare Technologies 的股份增加了 49.9%。摩根大通目前擁有 5,140,549 股公司股票，價值 414,894,000 美元，在此期間又購買了 1,711,963 股。Nuveen LLC 在第一季度收購了價值 77,058,000 美元的 GE HealthCare Technologies 新股份。Eminence Capital LP 在第一季度將其在 GE HealthCare Technologies 的持股增加了 38.7%。Eminence Capital LP 目前擁有 1,819,129 股公司股票，價值 146,822,000 美元，在此期間又購買了 507,101 股。加拿大養老金計劃投資委員會在第一季度將其在 GE HealthCare Technologies 的股份增加了 15.2%。加拿大養老金計劃投資委員會目前擁有 3,111,398 股公司股票，價值 251,121,000 美元，在上個季度又購買了 409,636 股。最後，瑞穗市場開曼有限公司在第二季度收購了價值約 29,628,000 美元的 GE HealthCare Technologies 新股份。目前 82.06% 的股票由機構投資者持有。</p>
</div><h2>GE HealthCare Technologies Stock Up 1.8%</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 股票上漲 1.8%</h2>
</div><p>GEHC stock opened at $72.31 on Thursday. The stock has a 50-day simple moving average of $74.77 and a two-hundred day simple moving average of $73.76. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The firm has a market capitalization of $32.94 billion, a PE ratio of 14.94, a PEG ratio of 2.97 and a beta of 1.13. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.</p>
<div class="lb-trans"><p>GEHC 股票週四開盤價為 72.31 美元。該股票的 50 日簡單移動平均線為 74.77 美元，200 日簡單移動平均線為 73.76 美元。GE HealthCare Technologies Inc.的 12 個月低點為 57.65 美元，12 個月高點為 94.80 美元。該公司的市值為 329.4 億美元，市盈率為 14.94，市盈增長比率為 2.97，貝塔值為 1.13。該公司的速動比率為 0.95，流動比率為 1.18，債務與股本比率為 0.83。</p>
</div><ul>
<li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>霍尼韋爾的拆分：HON 股票對投資者來説是個好交易嗎？</li>
</ul>
</div><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts' expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company's revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>GE HealthCare Technologies（NASDAQ:GEHC - 獲取免費報告）最近於 10 月 29 日（星期三）發佈了季度財報。該公司報告季度每股收益為 1.07 美元，超出市場共識預期的 1.05 美元 0.02 美元。該公司季度收入為 51.4 億美元，而分析師預期為 50.7 億美元。GE HealthCare Technologies 的股本回報率為 22.52%，淨利潤率為 10.94%。與去年同期相比，該公司的收入增長了 5.8%。去年同期，該公司每股收益為 1.14 美元。GE HealthCare Technologies 已將其 2025 財年的指導目標設定為每股收益 4.510-4.630 美元。平均而言，股票分析師預測 GE HealthCare Technologies Inc.在當前財年將發佈每股收益 4.68 美元。</p>
</div><h2>GE HealthCare Technologies Announces Dividend</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 宣佈分紅</h2>
</div><p>The company also recently announced a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 24th were given a $0.035 dividend. The ex-dividend date was Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's payout ratio is presently 2.89%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，已於 11 月 14 日（星期五）支付。10 月 24 日（星期五）登記的投資者獲得了 0.035 美元的分紅。除息日為 10 月 24 日（星期五）。這代表着年化分紅為 0.14 美元，收益率為 0.2%。GE HealthCare Technologies 的派息比率目前為 2.89%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><ul>
<li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li>
</ul>
<div class="lb-trans"><ul>
<li>超聲波減肥：GE HealthCare 與諾和諾德的合作</li>
</ul>
</div><p>A number of equities research analysts have commented on the company. Citigroup cut GE HealthCare Technologies from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and reduced their price objective for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Barclays initiated coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an &#34;equal weight&#34; rating and a $86.00 price target for the company. BTIG Research set a $87.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday, October 29th. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an &#34;equal weight&#34; rating in a report on Thursday, October 30th. Finally, Evercore ISI upped their target price on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an &#34;outperform&#34; rating in a report on Thursday, October 30th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $86.10.</p>
<div class="lb-trans"><p>一些股票研究分析師對該公司進行了評論。花旗集團在 10 月 7 日（星期二）的研究報告中將 GE HealthCare Technologies 的評級從 “買入” 下調至 “中性”，並將其目標價從 93.00 美元下調至 83.00 美元。巴克萊在 10 月 13 日（星期一）的研究報告中對 GE HealthCare Technologies 的股票進行了覆蓋，給予 “持平” 評級和 86.00 美元的目標價。BTIG 研究在 10 月 29 日（星期三）的研究報告中設定了 GE HealthCare Technologies 的目標價為 87.00 美元。摩根士丹利在 10 月 30 日（星期四）將 GE HealthCare Technologies 的目標價從 74.00 美元上調至 80.00 美元，並給予該公司 “持平” 評級。最後，Evercore ISI 在 10 月 30 日（星期四）將 GE HealthCare Technologies 的目標價從 88.00 美元上調至 92.00 美元，並給予該股票 “跑贏大盤” 評級。六位投資分析師對該股票給予 “買入” 評級，六位分析師對該公司的股票給予 “持有” 評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “適度買入”，共識目標價為 86.10 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on GE HealthCare Technologies</strong></p>
<div class="lb-trans"><p><strong>獲取我們對 GE HealthCare Technologies 的最新股票分析</strong></p>
</div><h2>GE HealthCare Technologies Profile</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.</p>
<div class="lb-trans"><p>GE HealthCare Technologies Inc.從事產品、服務和補充數字解決方案的開發、製造和營銷，這些產品、服務和解決方案用於美國、加拿大及國際上患者的診斷、治療和監測。該公司通過四個部門運營：成像、超聲、患者護理解決方案和藥物診斷。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than GE HealthCare Technologies</li>
<li>The 3 Best Retail Stocks to Shop for in August</li>
<li>onsemi Places a $6 Billion Bet on Its Own Stock</li>
<li>Large Cap Stock Definition and How to Invest</li>
<li>HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?</li>
<li>What is a Secondary Public Offering? What Investors Need to Know</li>
<li>End the Year Strong With These 3 Comeback Champions</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 GE HealthCare Technologies 更好</li>
<li>八月值得關注的三隻最佳零售股票</li>
<li>onsemi 對其自身股票下注 60 億美元</li>
<li>大盤股的定義及如何投資</li>
<li>HIMS 經歷了過山車，投資者應該上車嗎？</li>
<li>什麼是二次公開募股？投資者需要知道什麼</li>
<li>以這三隻反彈冠軍強勢結束年末</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding GEHC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 GEHC 持有股份的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=GEHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 GE HealthCare Technologies 嗎？</h2>
</div><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 GE HealthCare Technologies 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 GE HealthCare Technologies 並不在名單上。</p>
</div><p>While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 GE HealthCare Technologies 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Citizens Financial Group Inc. RI 在 GE HealthCare Technologies Inc. $GEHC 中新增了 27.6 萬美元的投資